PLXNA4
Plexin-A4
Also known as: DKFZp434G0625PRO34003, FAYV2820, KIAA1550, PLXA4_HUMAN, PLXNA4A, PLXNA4B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HCM2
- Gene
- PLXNA4
- Ensembl
- ENSG00000221866
- Chromosome
- 7
- Canonical length
- 1894 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
Predicted to enable semaphorin receptor activity. Predicted to be involved in nervous system development; regulation of cell migration; and semaphorin-plexin signaling pathway. Predicted to act upstream of or within nervous system development; regulation of axon extension involved in axon guidance; and regulation of negative chemotaxis. Predicted to be located in membrane. Predicted to be part of semaphorin receptor complex. Predicted to be active in cerebellar climbing fiber to Purkinje cell synapse and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
1894 residues, UniProt reviewed canonical sequence.
>Q9HCM2|PLXNA4
1 MKAMPWNWTC LLSHLLMVGM GSSTLLTRQP APLSQKQRSF VTFRGEPAEG FNHLVVDERT
61 GHIYLGAVNR IYKLSSDLKV LVTHETGPDE DNPKCYPPRI VQTCNEPLTT TNNVNKMLLI
121 DYKENRLIAC GSLYQGICKL LRLEDLFKLG EPYHKKEHYL SGVNESGSVF GVIVSYSNLD
181 DKLFIATAVD GKPEYFPTIS SRKLTKNSEA DGMFAYVFHD EFVASMIKIP SDTFTIIPDF
241 DIYYVYGFSS GNFVYFLTLQ PEMVSPPGST TKEQVYTSKL VRLCKEDTAF NSYVEVPIGC
301 ERSGVEYRLL QAAYLSKAGA VLGRTLGVHP DDDLLFTVFS KGQKRKMKSL DESALCIFIL
361 KQINDRIKER LQSCYRGEGT LDLAWLKVKD IPCSSALLTI DDNFCGLDMN APLGVSDMVR
421 GIPVFTEDRD RMTSVIAYVY KNHSLAFVGT KSGKLKKIRV DGPRGNALQY ETVQVVDPGP
481 VLRDMAFSKD HEQLYIMSER QLTRVPVESC GQYQSCGECL GSGDPHCGWC VLHNTCTRKE
541 RCERSKEPRR FASEMKQCVR LTVHPNNISV SQYNVLLVLE TYNVPELSAG VNCTFEDLSE
601 MDGLVVGNQI QCYSPAAKEV PRIITENGDH HVVQLQLKSK ETGMTFASTS FVFYNCSVHN
661 SCLSCVESPY RCHWCKYRHV CTHDPKTCSF QEGRVKLPED CPQLLRVDKI LVPVEVIKPI
721 TLKAKNLPQP QSGQRGYECI LNIQGSEQRV PALRFNSSSV QCQNTSYSYE GMEINNLPVE
781 LTVVWNGHFN IDNPAQNKVH LYKCGAMRES CGLCLKADPD FACGWCQGPG QCTLRQHCPA
841 QESQWLELSG AKSKCTNPRI TEIIPVTGPR EGGTKVTIRG ENLGLEFRDI ASHVKVAGVE
901 CSPLVDGYIP AEQIVCEMGE AKPSQHAGFV EICVAVCRPE FMARSSQLYY FMTLTLSDLK
961 PSRGPMSGGT QVTITGTNLN AGSNVVVMFG KQPCLFHRRS PSYIVCNTTS SDEVLEMKVS
1021 VQVDRAKIHQ DLVFQYVEDP TIVRIEPEWS IVSGNTPIAV WGTHLDLIQN PQIRAKHGGK
1081 EHINICEVLN ATEMTCQAPA LALGPDHQSD LTERPEEFGF ILDNVQSLLI LNKTNFTYYP
1141 NPVFEAFGPS GILELKPGTP IILKGKNLIP PVAGGNVKLN YTVLVGEKPC TVTVSDVQLL
1201 CESPNLIGRH KVMARVGGME YSPGMVYIAP DSPLSLPAIV SIAVAGGLLI IFIVAVLIAY
1261 KRKSRESDLT LKRLQMQMDN LESRVALECK EAFAELQTDI HELTSDLDGA GIPFLDYRTY
1321 TMRVLFPGIE DHPVLRDLEV PGYRQERVEK GLKLFAQLIN NKVFLLSFIR TLESQRSFSM
1381 RDRGNVASLI MTVLQSKLEY ATDVLKQLLA DLIDKNLESK NHPKLLLRRT ESVAEKMLTN
1441 WFTFLLYKFL KECAGEPLFS LFCAIKQQME KGPIDAITGE ARYSLSEDKL IRQQIDYKTL
1501 VLSCVSPDNA NSPEVPVKIL NCDTITQVKE KILDAIFKNV PCSHRPKAAD MDLEWRQGSG
1561 ARMILQDEDI TTKIENDWKR LNTLAHYQVP DGSVVALVSK QVTAYNAVNN STVSRTSASK
1621 YENMIRYTGS PDSLRSRTPM ITPDLESGVK MWHLVKNHEH GDQKEGDRGS KMVSEIYLTR
1681 LLATKGTLQK FVDDLFETIF STAHRGSALP LAIKYMFDFL DEQADKHGIH DPHVRHTWKS
1741 NCLPLRFWVN MIKNPQFVFD IHKNSITDAC LSVVAQTFMD SCSTSEHRLG KDSPSNKLLY
1801 AKDIPSYKNW VERYYSDIGK MPAISDQDMN AYLAEQSRMH MNEFNTMSAL SEIFSYVGKY
1861 SEEILGPLDH DDQCGKQKLA YKLEQVITLM SLDSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PLXNA4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 13 nTPM
- cervix: 7.9 nTPM
- breast: 7.4 nTPM
- cerebral cortex: 6.4 nTPM
- hippocampal formation: 6.2 nTPM
- blood vessel: 5.2 nTPM
Single-cell type
- adipocytes: 780 nCPM
- pituitary stem cells: 380 nCPM
- epicardial cells: 348 nCPM
- pdcs: 319 nCPM
- brain excitatory neurons: 297 nCPM
- mesothelial cells: 278 nCPM
Immune cell
- plasmacytoid DC: 2.6 nTPM
- NK-cell: 0.5 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebral cortex: 92 nTPM
- hippocampal formation: 85 nTPM
- white matter: 40 nTPM
- amygdala: 37 nTPM
- basal ganglia: 37 nTPM
- pons: 34 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PLXNA4.
Disease | ImmuneIEDB
Conditions an epitope on PLXNA4 was assayed in.
- berylliosis T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.23
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.8
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anterior commissure morphogenesis
- axon guidance
- branchiomotor neuron axon guidance
- embryonic heart tube development
- facial nerve structural organization
- glossopharyngeal nerve morphogenesis
- maintenance of synapse structure
- motor neuron axon guidance
- postganglionic parasympathetic fiber development
- regulation of axon extension involved in axon guidance
- regulation of cell migration
- semaphorin-plexin signaling pathway
- sympathetic nervous system development
- sympathetic neuron axon guidance
- synapse assembly
- trigeminal nerve structural organization
- vagus nerve morphogenesis
- chemorepulsion of branchiomotor axon
- regulation of negative chemotaxis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Sema domain
- Plexin repeat
- IPT domain
- Rho GTPase activation protein
- Plexin, cytoplasmic RasGAP domain
- Immunoglobulin-like fold
- Immunoglobulin E-set
- WD40/YVTN repeat-like-containing domain superfamily
- PSI domain
- Plexin family
- Sema domain superfamily
- Plexin, TIG domain 1
- Plexin, TIG domain 2
- Plexin, cytoplasmic RhoGTPase-binding domain
- Sema domain
- Plexin repeat
- IPT/TIG domain
- Plexin cytoplasmic RasGAP domain
- TIG domain
- TIG domain found in plexin
- Plexin cytoplasmic RhoGTPase-binding domain
- Plexin A/B, PSI domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PLXNA4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PLXNA4 as an antibody target. Whether an autoantibody or antibody against PLXNA4 could matter depends on whether native PLXNA4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PLXNA4 is annotated at the cell surface, where native PLXNA4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PLXNA4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...